Lupin falls 5% on Mylan drug launch, downgrade

Pharma firms stare at setbacks in the new regime. Consumers may celebrate the new drug price control order (DPCO), which was unveiled Thursday, as it promises to lower drug prices up to 80%. But pharmaceutical companies are staring at potential ...

In an affirmative sign, Ranbaxy shrugged off early losses after Monday's ruling to steadily climb 1.75 percent to Rs 463.45 on Wednesday on the Bombay Stock Exchange after analysts said the settlement of the US lawsuit clears a big overhang on the ...

How will Ranbaxy Laboratories' $500 million manufacturing settlement affect its business in the U.S.? Take your pick: It will either revive the company's exports to the States, or it will drag down its U.S. reputation, adding insult to the injury of ...

Ranbaxy Laboratories Ltd. (RBXY) may resume exports of drugs from two plants in India after resolving U.S. criminal charges that it sold adulterated medication, said analysts including Ranjit Kapadia at Centrum Broking Pvt. India's largest drugmaker ...

lost 2.6 per cent on the bourses, closing at Rs 2,026.30 after the company's March quarter numbers, especially on the margins front, were lower than expectations. While revenues grew a steady 26 per cent, gross margins at 50.43 per cent were 212 ...

Shares of drug maker Ranbaxy Laboratories ended 3.6% up at Rs. 455.50 on Tuesday after crashing 4% in early trade on the Bombay Stock Exchange following a $500-million (about Rs. 2,750 crore) fine imposed by US authorities on the company for selling ...

Less than two weeks after MiD DAY highlighted the pathetic state of the Dr HD Kanga Memorial Library, the Mumbai Cricket Association has taken steps towards improving things at the book temple housed at the Wankhede Stadium. Wisden Cricketers ...

Shares gain on hopes that growth in the domestic market would remain strong, analysts say. Top Stories Shares in Indian pharmaceutical companies such as Dr Reddy's Laboratories Ltd gain 4.8 percent after hitting an all-time high of 2,000 rupees on ...

(Mint - McClatchy-Tribune Information Services via COMTEX News Network) -- India's Rs.73,000 crore drugs market grew at the slowest pace in three years in the last quarter of fiscal 2013 because of a seasonal impact and a slump in the economy, ...